Skip to main content

News

May 04, 2021
CereMetrix 2.0 leverages the platform’s quantitative SPECT imaging and reporting capabilities to accommodate a broader range of modality agnostic clinical and research applications.
May 04, 2021
Breakthrough Designation Helps Advance Treatment Options, Targeting a Significant Unmet Need in the Treatment of CLTI. Micro Medical Solutions (MMS), focused on the treatment of CLTI, today announced that the U.S. Food and Drug Administration (FDA)…
April 21, 2021
Cerus Endovascular Ltd., a privately held, commercial-stage medical device company, today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device Exemption (IDE) application to conduct a U.S. trial for the…
April 20, 2021
Stellarex is the only Drug-Coated Balloon (DCB) to consistently demonstrate no difference in mortality every year through five years when compared with percutaneous transluminal angioplasty (PTA), the current standard of care.
April 08, 2021
New customized, peer-to-peer coaching program fills gap in health and wellness intervention for vascular surgeons. The Society for Vascular Surgery (SVS) and the Academy for Surgical Coaching today announced a partnership to develop a first-of-its-…
April 05, 2021
Hancock Jaffe Laboratories, Inc., a developer of medical devices that restore cardiac and vascular health, today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational Device Exemption (IDE) application…
March 17, 2021
Transit Scientific announced it received CE Mark approval in the European Union for its non-tapered metal alloy XO Cross® Microcatheter platform.
March 02, 2021
Cook Medical’s Zenith® Fenestrated+ Endovascular Graft (ZFEN+) product has received Breakthrough Device designation from the US Food and Drug Administration (FDA). This designation is granted for devices that have the potential to provide more…
February 16, 2021
Trial to provide first clinical experience in fistula surveillance for early detection and prediction of fistula stenosis
February 10, 2021
Ruptured abdominal aortic aneurysms (rAAA) are responsible for nearly 2% of all deaths in U.S. men over the age of 65. Endovascular aneurysm repair (EVAR) has emerged as a newer and less invasive alternative to open repair for rAAA, and current…
Back to Top